Optical Genome Mapping Detects Hidden Genetic Causes of Pregnancy Loss
Two studies show the advanced technique can identify chromosomal abnormalities missed by traditional genetic testing methods.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
Study Finds Racial Disparities in Provider-Initiated Exome Reanalysis
A decade-long study shows lower rates of provider-initiated reanalysis among Hispanic, Asian, and Black patients compared with White patients.
Molecular Diagnostics
Latest
Long-Read Sequencing Provider Adds Oxford Nanopore Assays
Wasatch BioLabs expands service portfolio with pharmacogenomics panel, telomere sequencing, and mRNA vaccine quality control workflows.
Myriad Genetics, SOPHiA GENETICS Partner on Global Liquid Biopsy Companion Diagnostic
The collaboration combines Myriad’s US laboratory capabilities with SOPHiA’s decentralized network of more than 800 institutions across 70-plus countries.
Read More
Seegene, Springer Nature Launch $600K Grant Program for UTI Antibiotic Resistance Research
The program focuses on antibiotic resistance in urinary tract infections, with applications open until Nov 20.
Read More
PacBio Launches HiFi Sequencing Platform for Carrier Screening Market
The updated solutions leverage PacBio’s HiFi sequencing technology to allow clinical laboratories to consolidate multiple specialized assays into a single, scalable test.
Read More
Enhanced PCR Reporting Service Applies CLSI Guidelines to UTI Results
The service applies CLSI M100 guidelines to PCR reports, delivering insights on pathogens and resistance markers to support labs and physicians.
Read More
Rare Disease Test Expanded to Include Tandem Repeat and Mitochondrial Analysis
The expanded testing capabilities leverage long-read sequencing technology to detect disorders such as Fragile X syndrome, adult neurological conditions, certain ataxias, and more.
Read More
CLIA Accreditation Clears Path for CNSide Diagnostics’ CSF Assay Platform
Houston-based facility meets federal regulatory requirements for cerebrospinal fluid testing to detect central nervous system metastases.
Read More
CMS Sets Preliminary Payment Rate for Optical Genome Mapping CPT Code
The new Category I code for constitutional genetic disorders receives crosswalk pricing of $1,263.53, higher than comparable microarray codes.
Read More
New qPCR Multiplexing Probes Aim to Reduce Turnaround Times and Streamline Ordering
The probes allow up to 5-plex multiplexing and are paired with a modernized online tool for ordering qPCR components.
Read More
AI Companion Tool Identifies Food Triggers Based on IBS Sensitivity Testing
A new AI-powered platform provides meal suggestions, ingredient substitutions, and meal planning guidance to help patients avoid their identified trigger foods.
Read More
Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Read More
Sophia Genetics Partners with Belgian Hospital to Streamline Next-Generation Sequencing Workflows
Jessa Ziekenhuis will implement unified genomic testing platform across pathology operations, expecting to reduce hands-on time by up to 50%.
Read More
Roche Gains CE IVDR Approval for Expanded HER2 Companion Diagnostic
VENTANA HER2 (4B5) test is now CE-IVDR approved to identify HER2-ultralow breast cancer and HER2-positive biliary tract cancer patients.
Read More
Mass General Brigham Launches Genetic Test for Eight Cardiovascular Conditions
The clinician-ordered test integrates polygenic risk scores validated in over 236,000 participants from the NIH’s All of Us Research Program.
Read More
Foresight Diagnostics Reports Clinical Performance Data for ctDNA Assay in Early-Stage Lung Cancer
Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.
Read More
Quest Diagnostics Launches Pharmacogenomics Testing Service for Medication Guidance
New offering combines genetic testing with clinical decision support tools to help optimize medication selection and dosing across multiple specialties.
Read More